KCM
OPTN

Kennedy Capital Management’s OptiNose OPTN Stock Holding History

Kennedy Capital Management’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,072
Closed -$326K – 712
2019
Q2 		$326K Sell
3,072
-16,965
-85% -$2.23M 0.01% 669
2019
Q1 		$3.1M Buy
20,037
+37
+0.2% +$4.29K 0.07% 465
2018
Q4 		$1.86M Buy
+20,000
New +$2.86M 0.05% 542

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kennedy Capital Management's OPTN Position: Q3 2019 in Review

Kennedy Capital Management sold out of OptiNose (OPTN) in Q3 2019, closing a stake of 3,072 shares — an estimated $326K sold.

Kennedy Capital Management first reported a position in OPTN in Q4 2018 and held it in 3 quarters. The position peaked at $3.1M in Q1 2019. 77 funds tracked by Wall St. Rank hold OPTN as of Q3 2019.

  • Kennedy Capital Management reported no remaining OptiNose position as of Q3 2019 after selling out during the quarter.
  • Kennedy Capital Management sold 3,072 OptiNose shares in Q3 2019, an estimated $326K.
  • Kennedy Capital Management first reported a position in OptiNose in Q4 2018 and held it in 3 quarters.
  • Kennedy Capital Management's OptiNose position peaked at $3.1M in Q1 2019.
  • 77 funds tracked by Wall St. Rank held OptiNose as of Q3 2019.

Based on Kennedy Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.